Pharmaceuticals & Therapeutics

Natural Alternatives International posts a 23% sales surge but a wider net loss, betting on new financing and product innovation to fix profitability woes.

New report reveals how manual database changes expose financial firms to regulatory fines and AI-driven attacks, creating a critical operational risk.

SERB Pharma's acquisition of Idefirix® rights offers new hope to thousands of highly sensitized patients previously unable to receive a kidney transplant.

With backing from Bain Capital and Armistice, the life sciences firm's latest offering aims to fund its push to automate pharmaceutical quality control.

Kidney care giant DaVita unveils ambitious 2030 targets for transplants, health equity, and sustainability, raising the bar for the healthcare industry.

Midwest Technical Institute awards $305k to students, championing hands-on skills as a secure future in a job market increasingly shaped by AI.

Alaunos Therapeutics reports positive preclinical data for its oral metabolic drug, but with a perilous financial runway, the race for survival is on.

P+Ex appoints industry veteran Dr. Lesley Ko as Executive Director to lead the charge in making concrete preservation a cornerstone of global infrastructure.

Hong Kong's PolyU is leading a global charge, uniting scientists and masters to prove the medical power of Tai Chi and Qigong.

Beneath the roar of engines in Xinjiang's desert lies a story of national ambition, geopolitical strategy, and a state-owned giant's push for dominance.

New data reveals TARA-002 has a 55% complete response rate at one year for NMIBC, offering a promising, safer alternative to standard care.

Pharma veteran Shyamakant Giri takes the helm at Apothecon Group, signaling an aggressive push into global regulated markets backed by Everstone Capital.

Amid major Medicare policy shifts, Nuo Therapeutics reports a 169% revenue surge, positioning its Aurix wound care system as a key market disruptor.

A new study finds a minimally invasive procedure provides greater short-term weight loss than a popular pill, reshaping the debate on obesity treatment.

As its CFO presents at a top NYC conference, Healios K.K. advances novel stem cell treatments for ARDS, stroke, and cancer into critical global trials.

The biotech firm is set to launch its first commercial products, using an innovative strategy to tackle long-neglected markets in women's healthcare.

A new joint venture merges Arna's innovation with Slate Run's market muscle, launching a key diagnostic and targeting high-value specialty medicines.

A key workshop aims to bridge the gap between FDA policy and patient needs, seeking to streamline therapy development for millions with rare diseases.

Soaring costs and long waits at home are driving thousands of Europeans to Albania for dental implants, where clinics offer top-tier care for less.

A new report reveals a startling trend: fewer recall events are leading to a massive 27% surge in recalled units, signaling larger, more dangerous defects.